M. Alexandre

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 586 citations

Ritux 3, Pharmacology, Pharmacotherapy +2

Rituximab for Patients With Refractory Mucous Membrane Pemphigoid

C. Le Roux‐Villet, C. Prost‐Squarcioni, M. Alexandre et al. · Archives of Dermatology · 2011 · 144 citations · Full text

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect

D.M. Chen, Adefowope Odueyungbo, Eva Csinady et al. · British Journal of Dermatology · 2019 · 91 citations · Full text

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population

Marthe Plaquevent, F. Tétart, L. Fardet et al. · Journal of Investigative Dermatology · 2018 · 83 citations · Full text

French General Population, Higher Frequency, Bullous Pemphigoid Patients +2

A Prospective Study of Upper Aerodigestive Tract Manifestations of Mucous Membrane Pemphigoid

M. Alexandre, Marie-Dominique Brette, Francis Pascal et al. · Medicine · 2006 · 77 citations